We market well.
Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.
Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.
Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.
People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
recent work right here
GENEVA (Reuters) - People returning from areas where the Zika virus is found should follow safe sex practices or abstain from sex for at least eight weeks rather than just four, the World Health Organization (WHO) said on Tuesday.... PARIS (Reuters) - A Spanish woman won the right to use her dead husband's frozen sperm to try to have a baby when France's top administrative court upheld her appeal on Tuesday.... (Reuters) - Daiichi Sankyo Co Ltd said it will not proceed with the second part of its late-stage study on the lung cancer drug, patritumab.... LISBON (Reuters) - The drug ecstasy is making a comeback in Europe, spreading as a mainstream party narcotic away from its niche use at dance clubs and reaching new young users, the Lisbon-based European drug agency said on Tuesday in a report.... WASHINGTON (Reuters) - The U.S. Supreme Court on Tuesday rejected Cubist Pharmaceuticals Inc's bid to revive four patents for its antibiotic drug Cubicin, paving the way for rival Hospira Inc to introduce a generic version as soon as this year.... (Reuters) - Amicus Therapeutics Inc said on Tuesday the European Commission approved the use of migalastat, its experimental treatment for Fabry disease, an inherited disease that creates pain and burning in the hands and feet.... (Reuters) - StemCells Inc said on Tuesday it had terminated a mid-stage trial testing its therapy in spinal cord injury and that its board had decided to wind down the company.... ZURICH (Reuters) - Drugmaker Roche has received European approval for an injectable form of antibody therapy MabThera for people with chronic lymphocytic leukemia, the company said on Tuesday.... JERUSALEM (Reuters) - Approval for Israel-based Teva Pharmaceutical Industries' drug to treat the neurological disorder chorea has been held up by U.S. regulators seeking further blood studies, the company said on Tuesday.... ZURICH (Reuters) - Switzerland's biggest drugmakers are clashing over cheaper copies of pricey biotech drugs - one reason why Novartis is considering selling its $14 billion stake in cross-town rival Roche....